Vycor Medical (VYCO) Payables (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Payables data on file, last reported at $3.5 million in Q1 2026.

• Payables for Q1 2026 came in at $3.5 million, up 7.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 7.89% YoY), and the FY2025 annual result was $3.3 million, up 8.62% from the prior year.
• Payables advanced to $3.5 million in Q1 2026 per VYCO's latest filing, from $3.3 million in the prior quarter.
• Over five years, Payables peaked at $3.5 million in Q1 2026 and troughed at $426773.0 in Q2 2023.
• A 5-year average of $2.0 million and a median of $2.9 million in 2024 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2024: Payables declined 29.2% in 2022, then soared 581.33% in 2024.
• A 5-year view of Payables shows it stood at $524755.0 in 2022, then surged by 417.7% to $2.7 million in 2023, then rose by 12.89% to $3.1 million in 2024, then advanced by 8.62% to $3.3 million in 2025, then grew by 4.62% to $3.5 million in 2026.
• Business Quant data shows VYCO's Payables at $3.5 million in Q1 2026, $3.3 million in Q4 2025, and $3.4 million in Q3 2025.